Procter & Gamble Hygiene and Health Care Limited · NSE: PGHH · BSE: 500459
Procter & Gamble Hygiene and Health Care
Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 29 Jul 2026.
Q1 FY27 · Standalone
Revenue
891.46₹ Cr
−4.9% vs year ago
Net profit
126.27₹ Cr
−34.3% vs year ago
EPS, basic
38.90₹
−34.3% vs year ago
Net margin
14.2%
−6.3 pts vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 891.46 | −4.9% | 126.27 | −34.3% | 38.90 | 29 Jul 2026 |
| Q4 FY26Jan–Mar 2026 | 941.32 | — | 153.13 | — | 47.17 | 28 May 2026 |
| Q3 FY26Oct–Dec 2025 | 1,261.90 | +1.1% | 301.46 | +12.2% | 92.87 | 30 Jan 2026 |
| Q2 FY26Jul–Sep 2025 | 1,150.17 | +1.3% | 209.86 | −1.0% | 64.65 | 06 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 937.03 | +0.6% | 192.06 | +136.9% | 59.17 | 30 Jul 2025 |
| Q3 FY25Oct–Dec 2024 | 1,247.63 | +10.1% | 268.59 | +17.3% | 82.74 | 11 Feb 2025 |
| Q2 FY25Jul–Sep 2024 | 1,135.16 | −0.3% | 211.90 | +0.6% | 65.28 | 30 Oct 2024 |
| Q1 FY25Apr–Jun 2024 | 931.75 | +9.3% | 81.06 | −46.4% | 24.97 | 29 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 1,002.17 | +13.5% | 154.37 | −6.5% | 47.56 | 02 May 2024 |
| Q3 FY24Oct–Dec 2023 | 1,133.43 | −0.3% | 228.90 | +10.3% | 70.51 | 01 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 1,138.35 | +8.9% | 210.69 | +36.4% | 64.91 | 31 Oct 2023 |
| Q1 FY24Apr–Jun 2023 | 852.53 | +9.8% | 151.24 | +255.4% | 46.59 | 29 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 883.09 | −9.3% | 165.02 | +60.4% | 50.84 | 11 May 2023 |
| Q3 FY23Oct–Dec 2022 | 1,137.39 | +4.1% | 207.47 | −2.2% | 63.91 | 01 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 1,044.89 | −1.3% | 154.41 | −29.3% | 47.57 | 03 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 776.38 | −1.3% | 42.55 | −13.1% | 13.11 | 24 Aug 2022 |
| Q4 FY22Jan–Mar 2022 | 973.26 | +28.1% | 102.85 | +4.6% | 31.68 | 28 Apr 2022 |
| Q3 FY22Oct–Dec 2021 | 1,092.98 | +7.3% | 212.06 | −15.4% | 65.33 | 01 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 1,058.30 | +4.8% | 218.29 | −14.0% | 67.25 | 02 Nov 2021 |
| Q1 FY22Apr–Jun 2021 | 786.59 | +24.0% | 48.98 | −29.2% | 15.09 | 26 Aug 2021 |
| Q4 FY21Jan–Mar 2021 | 759.66 | +15.8% | 98.33 | +7.9% | 30.29 | 04 May 2021 |
| Q3 FY21Oct–Dec 2020 | 1,018.44 | +18.5% | 250.62 | +84.4% | 77.21 | 04 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 1,009.45 | +18.5% | 253.86 | +85.5% | 78.21 | 10 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 634.53 | −0.4% | 69.21 | +13.9% | 21.32 | 25 Aug 2020 |
| Q4 FY20Jan–Mar 2020 | 656.05 | −6.2% | 91.10 | +1.1% | 28.07 | 09 May 2020 |
| Q3 FY20Oct–Dec 2019 | 859.27 | +5.0% | 135.93 | +9.5% | 41.88 | 12 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 852.14 | +7.6% | 136.84 | −5.0% | 42.16 | 06 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 637.29 | +21.5% | 60.79 | +36.5% | 18.73 | 21 Aug 2019 |
| Q4 FY19Jan–Mar 2019 | 699.34 | — | 90.11 | — | 27.76 | 09 May 2019 |
| Q3 FY19Oct–Dec 2018 | 818.07 | — | 124.12 | — | 38.24 | 08 Feb 2019 |
| Q2 FY19Jul–Sep 2018 | 791.80 | — | 144.11 | — | 44.40 | 03 Nov 2018 |
| Q1 FY19Apr–Jun 2018 | 524.65 | — | 44.55 | — | 13.72 | 23 Aug 2018 |
32 filings on record for this company.